In addition to these most popular options, other medications are available, but they require daily injections, making them less convenient than semaglutide
Unregulated BPC-157 products pose risks including contamination, incorrect dosages, and unknown interactions with prescribed medications
However, it is unsafe for pregnant or breastfeeding women, as it can cause serious congenital disabilities and developmental issues in babies
For instance, a small proportion of people have genetically low b12 values, while they do not have a deficiency
Semaglutide is administered as a once-weekly subcutaneous injection (marketed as Ozempic for diabetes and Wegovy for weight management) or as a daily oral tablet (Rybelsus)
10.1093/cvr/cvq076 18 BruenR.CurleyS.KajaniS.CreanD.O'ReillyM